MA H1074 | 2023-2024 | 193rd General Court
Note: Replaces legislation S689
Status
Spectrum: Moderate Partisan Bill (Democrat 66-12)
Status: Introduced on February 16 2023 - 25% progression, died in chamber
Action: 2024-12-31 - No further action taken
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 16 2023 - 25% progression, died in chamber
Action: 2024-12-31 - No further action taken
Text: Latest bill text (Introduced) [PDF]
Summary
Relative to cancer patient access to biomarker testing to provide appropriate therapy. Financial Services.
Title
Relative to cancer patient access to biomarker testing to provide appropriate therapy
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-12-31 | House | No further action taken |
| 2024-06-20 | House | Committee recommended bill ought to pass and referred to the committee on House Ways and Means |
| 2024-06-20 | House | Accompanied by S689 |
| 2024-05-23 | House | Reported favorably by committee and referred to the Joint Committee on Health Care Financing |
| 2024-03-28 | Senate | Senate concurred |
| 2024-02-08 | House | Reporting date extended to Friday May 17, 2024, pending concurrence |
| 2023-04-28 | Joint | Hearing rescheduled to 05/02/2023 from 10:00 AM-01:00 PM in Gardner Auditorium |
| 2023-04-18 | Joint | Hearing scheduled for 05/02/2023 from 10:00 AM-01:00 PM in A2 and virtual |
| 2023-02-16 | Senate | Senate concurred |
| 2023-02-16 | House | Referred to the Joint Committee on Financial Services |
Same As/Similar To
S689 (Replaces) 2024-06-20 - Accompanied H1074
Massachusetts State Sources
| Type | Source |
|---|---|
| Summary | https://malegislature.gov/Bills/193/H1074 |
| Text | https://malegislature.gov/Bills/193/H1074.pdf |
